ColdChain Trust
Pharma Cold Chain Assurance
End-to-end pharmaceutical cold chain monitoring with immutable audit trails. Ensure vaccine and biologic integrity from manufacturer to patient.
Per month, billed monthly
- IoT Temperature Monitoring
- Immutable Audit Trail
- Excursion Response
- DSCSA Compliance
Start with a 14-day free trial. No credit card required.
The Problem
$35B in biologics are lost annually to temperature excursions. Manual temperature logs and fragmented monitoring create compliance risk and patient safety concerns.
- $35B/year in temperature-related biologic losses
- 40% of vaccines experience temperature excursions
- Manual temperature logs are error-prone and fraud-susceptible
- DSCSA compliance requires end-to-end traceability
The Solution
ColdChain Trust provides real-time IoT temperature monitoring with blockchain-verified audit trails and automated DSCSA compliance documentation.
IoT Temperature Monitoring
Continuous temperature and humidity monitoring with configurable alert thresholds.
Immutable Audit Trail
Blockchain-verified temperature logs that cannot be altered — critical for FDA and EMA audits.
Excursion Response
Automated excursion protocols with stability budget calculations and disposition recommendations.
DSCSA Compliance
End-to-end traceability from manufacturer to dispenser meeting all DSCSA 2023 requirements.
Key Features
Everything you need in one platform.
IoT Temperature Monitoring
Continuous temperature and humidity monitoring with configurable alert thresholds.
Immutable Audit Trail
Blockchain-verified temperature logs that cannot be altered — critical for FDA and EMA audits.
Excursion Response
Automated excursion protocols with stability budget calculations and disposition recommendations.
DSCSA Compliance
End-to-end traceability from manufacturer to dispenser meeting all DSCSA 2023 requirements.
Ready to Get Started?
Try ColdChain Trust free for 14 days. No credit card required. No contracts. Just better software.
Frequently Asked Questions
Everything you need to know about the product.